Viridans streptococci bacteraemia
|Publication: 18/11/2014 --|
|Last review: 23/03/2020|
|Next review: 23/03/2023|
|Approved By: Trust Clinical Guidelines Group|
|Copyright© Leeds Teaching Hospitals NHS Trust 2020|
This Clinical Guideline is intended for use by healthcare professionals within Leeds unless otherwise stated.
Department of Microbiology Bacteraemia Guideline
- About Viridans Streptococci
- Antimicrobial susceptibilities
- Clinical differential diagnosis
- Antimicrobial treatment
- Supplementary investigations
Quick reference guide to the management of Viridans Streptococci
This document provides guidelines for doctors on the management of patients with confirmed bacteraemias (blood cultures). This document is supplementary to, and should be used in conjunction with, the antimicrobial guidelines.
The aim of this guideline is to:
- Provide education to junior microbiology registrars
- Support communication of blood culture results from microbiologists to ward doctors
- Support ward doctors in treating and investigating bacteraemic patients
The blood culture process: Timings of culture, identification, susceptibility tests and clinical liaison.
How to use this guideline: This guideline should be used to help in the management of patients with a confirmed bacteraemia. The guideline should be used to support interaction with specialist advice e.g. Microbiology.
- Viridans Streptococci are gram-positive cocci which appear as spherical or ovoid cells that form chains or pairs. The term viridans derives from the Latin word viridis, meaning green ,as they may cause green discoloration on blood agar ( a-haemolysis)
- Clinically significant species of viridans streptococci can be assigned to one of the following groups: the mitis group, the mutans group, the salivarius group and the sanguinis group. Streptococcus anginosus (includingS. milleri) group is also classified among the Viridans Streptococci (see separate guideline)
- Viridans Streptococci are found as part of the normal bacteria colonising the upper respiratory tract, female genital tract and gastrointestinal tract but are most prevalent in the oral cavity.
- Viridans streptococci are considered to be bacteria of low virulence
- Only 21% of positive blood cultures with Viridans Streptococci are thought to be significant. The remainder have been attributed to contamination3. Bacteraemia -without endocarditis-has been recognised as a problem in patients undergoing cancer chemotherapy4 and in patients with end-stage liver disease5
- Viridans Streptococci are susceptible to most antimicrobial agents, including β-lactams, macrolides, tetracyclines, quinolones and aminoglycosides. Generally community acquired isolates tend to be highly susceptible6 and resistance occurs more frequently in nosocomial infections or immunocompromised patients7,8
- Vancomycin, linezolid, daptomycin and tigecycline have good antimicrobial activity against Streptococci.
The differential diagnosis of bacteraemia with Viridans Streptococci includes:
- Central venous catheter infections
- Aspiration pneumonia
- Spontaneous Bacterial Peritonitis (SBP)
- Other infections caused rarely (meningitis, otitis media, sinusitis, dental infections)
- Antibiotic therapy should always be reviewed with results of sensitivity tests.
- Viridans Streptococcal bacteraemias should normally be discussed with an infection specialist e.g. microbiologist.
History of the following are important to determine appropriate antimicrobial therapy
- Source of infection
- Allergy status
The table below outlines some of the common infections associated with each of the clinical syndromes.
Central venous access infections
Spontaneous Bacterial Peritonitis
Consider further investigations as appropriate to source of infection, please see relevant guidelines.
|Target patient group:|
|Target professional group(s):||Secondary Care Doctors
- Swenson FJ etal. Clinical significance of viridans streptococci isolated from blood cultures. J Clin Microbiol 1982;15:725-727
- Engelhard D et al. Cytoside arabinoside as a major risk factor for Streptococcus viridans septicaemia following bone marrow transplantation. A 5-year prospective study. Marrow Tranplant 1995 ;16:565-70
- Bert F et al. Viridans group streptococci causing spontaneous bacterial peritonitis and bacteraemia in patients with end-stage lever disease. Liver Transplant. 2008;14:710-711
- Francioli PB. Ceftriaxone and outpatient treatment for infective endocarditis.Inf Dis Clin North A, 1993;7:97-115
- Pfaller MA et al. nosocomial streptococcal bloodstream infections in the SCOPE program:Species occurrence and antimicrobial susceptibility. Diagn Microbiol Infect Dis .1997;29:259-63
- Trends in Antimicrobial Resistance in England and Wales 2004-2005. HPA
Trust Clinical Guidelines Group
LHP version 1.0
Equity and Diversity
The Leeds Teaching Hospitals NHS Trust is committed to ensuring that the way that we provide services and the way we recruit and treat staff reflects individual needs, promotes equality and does not discriminate unfairly against any particular individual or group.